![Emmett Cunningham](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emmett Cunningham
Director/Board Member at GALERA THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Young | M | 79 |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts.
SFJ Pharmaceuticals, Inc.
![]() SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | 15 years |
Richard Hawkins | M | 75 |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | 14 years |
Robert DeBenedetto | M | - |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts.
SFJ Pharmaceuticals, Inc.
![]() SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | 8 years |
Jonathan Gray | M | 54 | 32 years | |
Chris Degnan | M | 44 | 5 years | |
Stephen Schwarzman | M | 77 | 39 years | |
Thomas Wiggans | M | 72 | 7 years | |
John McKew | M | 59 | 8 years | |
Douglas Love | M | 56 | 10 years | |
Leah Makley | M | - |
Viewpoint Therapeutics, Inc.
![]() Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | 10 years |
J. Sorensen | M | 67 | 12 years | |
Brian D. Lawrence | M | - |
Silk Technologies Ltd.
![]() Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Silk Technologies Ltd. develops silk-derived protein (SDP) products for ophthalmic applications. Its patented SDP material is currently being developed as a compound for the treatment of patients with dry eye disease. The company was founded by Brian D. Lawrence and is headquartered in Plymouth, MN. | - |
Bradley Powers | M | 45 | 5 years | |
Kiran Reddy | M | 47 |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | 4 years |
Nicholas G. Galakatos | M | 66 |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | 14 years |
Jean Rogers | F | - | - | |
Edward Hurwitz | M | 60 |
Viewpoint Therapeutics, Inc.
![]() Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | 10 years |
Jennifer Stacey | F | 59 | 3 years | |
Michael Powell | M | 69 | 8 years | |
Reginald Brown | M | 56 | 4 years | |
Jennifer Lew | F | 51 | 5 years | |
Rochelle Lazarus | F | 76 | 11 years | |
Cameron Wheeler | M | 45 |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | 5 years |
Lindsay Gibson | F | - | 5 years | |
John Finley | M | 67 | 14 years | |
Lawrence Alleva | M | 74 | 5 years | |
Jung Choi | F | 54 | 4 years | |
Anthony Riccio | M | - | - | |
Alejandro Dorenbaum | M | 64 |
The University of California, San Francisco
Stanford University School of Medicine
| 9 years |
Ajay Madan | M | - |
Healthquest Capital Management Co LLC
![]() Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | 1 years |
Barry Gertz | M | 72 |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
Lazar Dimitrov | M | - |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts.
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | - |
Avery Williams | F | - |
Healthquest Capital Management Co LLC
![]() Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | 2 years |
Kelly Ayotte | F | 56 | 5 years | |
Christopher Striano | M | - | - | |
Michael Snyder | M | - |
Stanford University School of Medicine
| 15 years |
Dennis P. Riley | M | - | 15 years | |
Chad Johnson | M | 45 | 6 years | |
Lori Lawley | F | 40 | 4 years | |
Christine Anderson | F | 47 | 15 years | |
Ruth Porat | F | 66 | 4 years | |
Vikrant Sawhney | M | 54 | 17 years | |
Lionel Yves Assant | M | 52 | - | |
Muneer Satter | M | 63 | 10 years | |
William Carson | M | 65 | 3 years | |
William Parrett | M | 78 | 17 years | |
Joseph McCracken | M | 70 | 4 years | |
Garheng Kong | M | 49 |
Healthquest Capital Management Co LLC
![]() Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | 12 years |
Cynthia Chiarappa | F | - |
California Pacific Medical Center
![]() California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | - |
Grant Davies | M | - |
California Pacific Medical Center
![]() California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | - |
Robert A. Heft | M | 69 |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | - |
Kevin Lokay | M | 67 | 5 years | |
Michael Chae | M | 55 | 27 years | |
Joseph Baratta | M | 53 | 26 years | |
David King | M | 67 |
Healthquest Capital Management Co LLC
![]() Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | 1 years |
Linda West | F | 64 | 4 years | |
Kenneth Caplan | M | 50 | 27 years | |
John P. Burnier | M | - |
SARcode Bioscience, Inc.
![]() SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | 18 years |
Jim Breyer | M | 62 | 8 years | |
Mintu Turakhia | M | 50 |
Stanford University School of Medicine
| 16 years |
Ramon Chavez Márquez | M | 60 |
Stanford University School of Medicine
| 9 years |
Peter Fitzgerald | M | 66 |
Stanford University School of Medicine
| 27 years |
Judith Ned | F | - |
Stanford University School of Medicine
| - |
Steven J. Chu | M | 76 |
Stanford University School of Medicine
| 11 years |
John W. Day | M | - |
Stanford University School of Medicine
| 13 years |
Vikram Bajaj | M | 46 |
Stanford University School of Medicine
| 10 years |
Ryan Spitler | M | - |
Stanford University School of Medicine
| 8 years |
Henry Greely | M | - |
Stanford University School of Medicine
| - |
Chris Zeise | M | - |
Stanford University School of Medicine
| - |
Jeffrey Olgin | M | - |
UCSF School of Medicine
| - |
Eleni Linos | F | - |
UCSF School of Medicine
| - |
Phil Yang | M | - |
Stanford University School of Medicine
| - |
Dean Sheppard | M | - |
UCSF School of Medicine
| - |
Kevin Lalande | M | 51 |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | - |
Lane Welton | M | - |
SARcode Bioscience, Inc.
![]() SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | 13 years |
Jillian Manus | F | - |
Stanford University School of Medicine
| 6 years |
K. Christopher Garcia | M | - |
Stanford University School of Medicine
| 25 years |
Amato Giaccia | M | 65 |
Stanford University School of Medicine
| - |
Lawrence M. Shuer | M | - |
Stanford University School of Medicine
| - |
Terrence Blaschke | M | 81 |
Stanford University School of Medicine
| 50 years |
Theodore Tussing | M | - |
Stanford University School of Medicine
| - |
Sandra Horning | M | 75 |
Stanford University School of Medicine
| - |
Joseph Wu | M | - |
Stanford University School of Medicine
| 11 years |
Pamela Palmer | M | 61 |
The University of California, San Francisco
| 28 years |
Daria Mochly-Rosen | M | - |
Stanford University School of Medicine
| - |
George W. Sledge | M | 73 |
Stanford University School of Medicine
| - |
Michelle Brandt | F | - |
Stanford University School of Medicine
| - |
Walter Greenleaf | M | - |
Stanford University School of Medicine
| 7 years |
An van Es-Johansson | M | 64 |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | 3 years |
Ed Mathers Mathers | M | 64 |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | - |
James Gillespie | M | - |
Stanford University School of Medicine
| 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Beardsley | M | 63 | 15 years | |
David Guyer | M | 64 |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 years |
Jeffrey L. Cleland | M | 59 | 4 years | |
Arnon Rosenthal | M | 68 | 6 years | |
Ricky Sun | M | 50 |
New York University
| 7 years |
Campbell Murray | M | 48 | 7 years | |
Ryan Rhodes | M | - | - | |
Frédéric Guerard | M | 51 | 4 years | |
Cheryl Mills | F | 59 |
New York University
| 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Emmett Cunningham
- Personal Network